Scandion Oncology A/S (SCOL) — Cash Flow Reinvestment Rate
Latest as of September 2020:
0.20x
Scandion Oncology A/S (SCOL) has a Cash Flow Reinvestment Rate of 0.20x as of September 2020, reinvesting Skr46.00K (capex Skr0.00 plus investments Skr-46.00K) from operating cash flow of Skr229.00K. See SCOL net asset quality score to measure how much of total assets are equity-financed.
Reinvestment Rate
0.20x
(Capex + Investments) / Operating CF
Total Reinvested
Skr46.00K
Capex + Investments
Operating Cash Flow
Skr229.00K
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Scandion Oncology A/S (None–None)
Year-by-year capital reinvestment analysis for Scandion Oncology A/S. For live market cap and broader valuation context, see SCOL market cap overview.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow